• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDZK1与高级别胶质瘤的动态对比增强磁共振成像(DCE-MRI)灌注参数相关。

PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.

作者信息

Zhang Yi, Wang Feng, Huang YongLi

机构信息

Department of Radiology, The First People's Hospital of Shuangliu District, (West China Airport Hospital of Sichuan University), Chengdu City, Sichuan Province, China.

Department of Radiology, The First People's Hospital of Shuangliu District, (West China Airport Hospital of Sichuan University), Chengdu City, Sichuan Province, China.

出版信息

Clinics (Sao Paulo). 2024 Apr 30;79:100367. doi: 10.1016/j.clinsp.2024.100367. eCollection 2024.

DOI:10.1016/j.clinsp.2024.100367
PMID:38692010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11070665/
Abstract

OBJECTIVE

This study investigated the relationship between PDZK1 expression and Dynamic Contrast-Enhanced MRI (DCE-MRI) perfusion parameters in High-Grade Glioma (HGG).

METHODS

Preoperative DCE-MRI scanning was performed on 80 patients with HGG to obtain DCE perfusion transfer coefficient (K), vascular plasma volume fraction (v), extracellular volume fraction (v), and reverse transfer constant (k). PDZK1 in HGG patients was detected, and its correlation with DCE-MRI perfusion parameters was assessed by the Pearson method. An analysis of Cox regression was performed to determine the risk factors affecting survival, while Kaplan-Meier and log-rank tests to evaluate PDZK1's prognostic significance, and ROC curve analysis to assess its diagnostic value.

RESULTS

PDZK1 was upregulated in HGG patients and predicted poor overall survival and progression-free survival. Moreover, PDZK1 expression distinguished grade III from grade IV HGG. PDZK1 expression was positively correlated with K, and v, and negatively correlated with k, and k.

CONCLUSION

PDZK1 is upregulated in HGG, predicts poor survival, and differentiates tumor grading in HGG patients. PDZK1 expression is correlated with DCE-MRI perfusion parameters.

摘要

目的

本研究调查了高级别胶质瘤(HGG)中PDZK1表达与动态对比增强磁共振成像(DCE-MRI)灌注参数之间的关系。

方法

对80例HGG患者进行术前DCE-MRI扫描,以获得DCE灌注转移系数(K)、血管血浆容积分数(v)、细胞外容积分数(v)和反向转移常数(k)。检测HGG患者中的PDZK1,并通过Pearson法评估其与DCE-MRI灌注参数的相关性。进行Cox回归分析以确定影响生存的危险因素,同时采用Kaplan-Meier法和对数秩检验评估PDZK1的预后意义,并通过ROC曲线分析评估其诊断价值。

结果

HGG患者中PDZK1上调,提示总体生存和无进展生存较差。此外,PDZK1表达可区分III级和IV级HGG。PDZK1表达与K和v呈正相关,与k和k呈负相关。

结论

HGG中PDZK1上调,提示生存较差,并可区分HGG患者的肿瘤分级。PDZK1表达与DCE-MRI灌注参数相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/44cf05a918f7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/fdf28388ee80/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/bb4e6ed17e12/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/44cf05a918f7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/fdf28388ee80/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/bb4e6ed17e12/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f15d/11070665/44cf05a918f7/gr3.jpg

相似文献

1
PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.PDZK1与高级别胶质瘤的动态对比增强磁共振成像(DCE-MRI)灌注参数相关。
Clinics (Sao Paulo). 2024 Apr 30;79:100367. doi: 10.1016/j.clinsp.2024.100367. eCollection 2024.
2
Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.术前动态对比增强磁共振成像灌注参数对高级别胶质瘤患者的预后价值
Neuroradiology. 2016 Dec;58(12):1197-1208. doi: 10.1007/s00234-016-1741-7. Epub 2016 Oct 29.
3
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
4
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.动态对比增强和动态磁敏感对比灌注磁共振成像用于胶质瘤分级:使用热点和直方图分析对血管腔室和通透性参数的初步比较
Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22.
5
Dynamic Contrast-enhanced MRI Processing Comparison for Distinguishing True Progression From Pseudoprogression in High-grade Glioma.动态对比增强磁共振成像处理在高级别胶质瘤中区分真性进展与假性进展的比较
J Comput Assist Tomogr. 2025;49(4):656-661. doi: 10.1097/RCT.0000000000001716. Epub 2025 Jan 27.
6
Presence of Fragmented Intratumoral Thrombosed Microvasculature in the Necrotic and Peri-Necrotic Regions on SWI Differentiates IDH Wild-Type Glioblastoma From IDH Mutant Grade 4 Astrocytoma.磁敏感加权成像(SWI)上坏死及坏死周边区域存在瘤内破碎血栓形成的微血管,可将异柠檬酸脱氢酶(IDH)野生型胶质母细胞瘤与IDH突变型4级星形细胞瘤区分开来。
J Magn Reson Imaging. 2025 Jul;62(1):258-270. doi: 10.1002/jmri.29695. Epub 2025 Jan 9.
7
Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.动态对比增强 MRI 预测 PTEN 蛋白表达,可作为 NPC 患者无进展生存的预后指标。
J Cancer Res Clin Oncol. 2022 Jul;148(7):1771-1780. doi: 10.1007/s00432-021-03764-7. Epub 2021 Aug 16.
8
Dynamic contrast enhanced MRI in nodal lymphoma: correlation of quantitative MR perfusion parameters with lymphoma subtype, Lugano stage, and Ki-67 index.动态对比增强磁共振成像在淋巴结淋巴瘤中的应用:定量磁共振灌注参数与淋巴瘤亚型、卢加诺分期及Ki-67指数的相关性
Br J Radiol. 2025 Apr 1;98(1168):586-591. doi: 10.1093/bjr/tqaf016.
9
Contrast-enhanced ultrasound can differentiate the level of glioma infiltration and correlate it with biological behavior: a study based on local pathology.超声造影可鉴别胶质瘤浸润程度并将其与生物学行为相关联:一项基于局部病理学的研究
J Ultrasound. 2025 Mar;28(1):63-74. doi: 10.1007/s40477-024-00961-1. Epub 2024 Nov 4.
10
Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.灌注磁共振成像作为贝伐单抗治疗复发性恶性胶质瘤的预测/预后及药效学生物标志物:一项系统评价和事件发生时间的荟萃分析
J Neurooncol. 2016 Jun;128(2):185-94. doi: 10.1007/s11060-016-2102-4. Epub 2016 Apr 23.

本文引用的文献

1
Mechanism of PDZK1 in Hepatocellular Carcinoma Complicated with Hyperuricemia.PDZK1在肝细胞癌合并高尿酸血症中的作用机制
J Oncol. 2022 Nov 14;2022:1403454. doi: 10.1155/2022/1403454. eCollection 2022.
2
Roles of circ_0000135/miR-140-3p/PDZK1 network in cervical cancer.circ_0000135/miR-140-3p/PDZK1网络在宫颈癌中的作用
Clin Transl Oncol. 2022 Jun;24(6):1086-1099. doi: 10.1007/s12094-021-02751-1. Epub 2022 Jan 23.
3
Roles and mechanisms of puerarin on cardiovascular disease:A review.葛根素对心血管疾病作用及机制的研究进展。
Biomed Pharmacother. 2022 Mar;147:112655. doi: 10.1016/j.biopha.2022.112655. Epub 2022 Jan 20.
4
Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.动态对比增强磁共振成像预测胶质母细胞瘤患者标准治疗后持续强化病变的进展:一项前瞻性研究。
Eur Radiol. 2017 Aug;27(8):3156-3166. doi: 10.1007/s00330-016-4692-9. Epub 2016 Dec 14.
5
Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.低级别与间变性少突胶质细胞瘤的动态对比增强磁共振成像
J Neuroimaging. 2016 May;26(3):366-71. doi: 10.1111/jon.12320. Epub 2015 Dec 26.
6
Prospective glioma grading using single-dose dynamic contrast-enhanced perfusion MRI.使用单剂量动态对比增强灌注磁共振成像进行前瞻性胶质瘤分级
Clin Radiol. 2015 Oct;70(10):1128-35. doi: 10.1016/j.crad.2015.06.076. Epub 2015 Jul 4.
7
Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.动态对比增强灌注磁共振成像与扩散加权成像在胶质瘤分级中的应用
J Neuroimaging. 2015 Sep-Oct;25(5):792-8. doi: 10.1111/jon.12239. Epub 2015 Apr 13.
8
Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.贝伐单抗治疗复发性胶质母细胞瘤中动态对比增强磁共振成像衍生的微血管通透性评估
J Neurooncol. 2015 Jan;121(2):373-80. doi: 10.1007/s11060-014-1644-6. Epub 2014 Oct 31.
9
Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI.通过治疗期间动态对比增强磁共振成像评估胶质母细胞瘤的无进展生存期
Clin Neuroradiol. 2016 Mar;26(1):39-45. doi: 10.1007/s00062-014-0328-0. Epub 2014 Aug 28.
10
EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.EBP50通过LIMK/丝切蛋白以及PI3K/Akt/mTOR/MMP信号通路抑制人乳腺癌细胞的迁移和侵袭。
Med Oncol. 2014 Sep;31(9):162. doi: 10.1007/s12032-014-0162-x. Epub 2014 Aug 14.